FibroBiologics announced that its Founder and CEO Pete O'Heeron and Chief Scientific Officer Hamid Khoja will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference. The chat is scheduled for 1:00 p.m. ET on June 30, 2026, and will be moderated by Matthew Caufield, Senior Research Healthcare Analyst at H.C. Wainwright & Co. FibroBiologics will also be available for one-on-one meetings throughout the event, which runs from June 30 to July 1, 2026.
FibroBiologics, Inc. Common StockCompany participation in a conference fireside chat is a routine investor relations activity with no material news.
Meta Platforms Inc.